20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand

Go back to 20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand
(NASDAQ: AIDX) Delayed: 0.61 -0.05 (7.58%)
Previous Close $0.66    52 Week High
Open $0.63    52 Week Low
Day High $0.63    P/E N/A 
Day Low $0.60    EPS
Volume 282,188